Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 3.7% in the afternoon session after BofA ...

Bank of America upgrades Bristol Myers to Buy, lifting its price target to $61 on pipeline catalysts, valuation support, and ...

Bristol Myers Squibb Company BMY has been performing well recently. Shares of this biotech giant have gained 13.1% in the ...

Bristol-Myers Squibb (BMY) has been quietly rebuilding momentum, with the stock up around 8% over the past month even as its ...

Fintel reports that on December 15, 2025, B of A Securities upgraded their outlook for Bristol-Myers Squibb (NYSE:BMY) from ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best pharma stocks to invest in. On December 4, Jefferies reiterated a ...

Bristol-Myers Squibb shares gained after the company announced that it will enroll additional patients in the ADEPT-2 study.

Share price of Bristol Myers Squibb (BMY) touched a 52-week low of $42.96 on July 31, post its second-quarter earnings release. The stock has recovered 6.7% since then and is currently trading at ...

The adjustment follows Goldman Sachs’ update on Bristol-Myers Squibb Company (NYSE:BMY) earlier in the month on December 2, ...

Bristol-Myers Squibb faces patent cliff risks despite strong drug revenues and a 4.8% yield. Click here to read my latest analysis of BMY stock.